Showing 1-10 of 27 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Clinical Translation of NICHE for pancreatic islet transplantation for T1D | Continuity Biosciences | Alessandro Grattoni | Cures | 01-March-2026 to 28-February-2030 | $2.675.316,00 |
| Cord Blood Proteomic Markers of Type 1 Diabetes Risk: Towards Validation in a Diverse Birth Cohort | University of Florida | Angelica Ahrens | Cures | 01-April-2026 to 31-March-2027 | $199.235,28 |
| Understanding Early Histopathological Changes in the Pancreas of those at Risk for Type 1 Diabetes Development | University of Florida | Alexandra Rippa | Cures | 01-March-2026 to 28-February-2029 | $237.690,00 |
| Nano-encapsulated microparticulate drug delivery platforms for decreasing islet graft immunogenicity | University of Miami | Dhanashree Surve | Cures | 01-March-2026 to 28-February-2029 | $274.010,00 |
| Towards an integrated proteomic and transcriptomic single-cell atlas of the human pancreas | University of Miami | Dirk Homann | Cures | 01-April-2025 to 31-March-2027 | $53.972,92 |
| Prohormone convertase activity in human T1D pancreas tissue slices | University of Florida | Denise Drotar | Cures | 01-March-2025 to 29-February-2028 | $264.895,00 |
| bifunctional RNA therapeutics for T1D | University of Miami | Paolo Serafini | Cures | 01-February-2025 to 31-January-2028 | $900.000,00 |
| Low-dose IL-2 and anti-CD40L as a therapy for type 1 diabetes | University of Miami | Thomas Malek | Cures | 01-June-2024 to 31-May-2027 | $927.000,00 |
| Preclinical development of the BMP receptor agonist THR-184 for beta cell regeneration | University of Miami | Juan Dominguez-Bendala | Cures | 01-April-2024 to 31-March-2027 | $741.000,00 |
| Combinational immune therapies with antigen-specific Tregs for tolerance induction in islet transplantation | University of Florida | Allison Bayer | Cures | 01-September-2023 to 31-March-2026 | $510.297,39 |